Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer

Cancer Research

Volumn 64, Issue 24, 2004, Pages 8932-8938

  Oliveira Ferrer, Leticia ^a   Tilki, Derya ^a   Ziegeler, Gudrun ^a   Hauschild, Jessica ^a   Loges, Sonja ^a   Irmak, Ster ^a   Kilic, Ergin ^a   Huland, Hartwig ^a   Friedrich, Martin ^a   Ergün, Süleyman ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; VASCULOTROPIN C; VASCULOTROPIN D;

ANGIOGENESIS; ARTICLE; BLADDER CANCER; CONTROLLED STUDY; ENDOTHELIUM; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSITIONAL CELL CARCINOMA; UROTHELIUM; WESTERN BLOTTING;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; URINARY BLADDER; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 10844256675     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0505     Document Type: Article

References (29)

1. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-64.
2. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-95.
3. Ergun S, Kilic N, Ziegeler G, et al. CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell 2000;5:311-20.
4. Wagener C, Ergun S. Angiogenic properties of the carcinoembryonic antigen-related cell adhesion molecule 1. Exp Cell Res 2000;261:19-24.
5. Rojas M, Fuks A, Stanners CP. Biliary glycoprotein, a member of the immunoglobulin supergene family, functions in vitro as a Ca2(+)-dependent intercellular adhesion molecule. Cell Growth Differ 1990;1:527-33.
6. Kuroki M, Arakawa F, Matsuo Y, Oikawa S, Nakazato H, Matsuoka Y. Three novel molecular forms of biliary glycoprotein deduced from cDNA clones from a human leukocyte library. Biochem Biophys Res Commun 1991;176:578-85.
7. Barnett TR, Drake L, Pickle W. Human biliary glycoprotein gene: characterization of a family of novel alternatively spliced RNAs and their expressed proteins. Mol Cell Biol 1993;13:1273-82.
8. Nollau P, Prall F, Helmchen U, Wagener C, Neumaier M. Dysregulation of carcino-embryonic antigen group members CGM2, CD66a (biliary glycoproiein), and non-specific cross-reacting antigen in colorectal carcinomas. Comparative analysis by northern blot and in situ hybridization. Am J Pathol 1997;151:521-30.
9. Lin SH, Pu YS. Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer. Semin Oncol 1999;26:227-33.
10. Volpert O, Luo W, Liu TJ, Estrera VT, Logothetis C, Lin SH. Inhibition of prostate tumor angiogenesis by the tumor suppressor CEACAM1. J Biol Chem 2002;277:35696-702.
11. Kleinerman DI, Dinney CP, Zhang WW, Lin SH, Van NT, Hsieh JT. Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model. Cancer Res 1996;56:3431-35.
12. Izzi L, Turbide C, Houde C, Kunath T, Beauchemin N. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function. Oncogene 1999;18:5563-72.
13. Singer BB, Scheffrahn I, Obrink B, The tumor growth-inhibiting cell adhesion molecule CEACAM1 (C-CAM) is differently expressed in proliferating and quiescent epithelial cells and regulates cell proliferation. Cancer Res 2000;60:1236-44.
14. Ebrahimnejad A, Flayeh R, Unteregger G, Wagener C, Brummer J. Cell adhesion molecule CEACAM1 associates with paxillin in granulocytes and epithelial and endothelial cells. Exp Cell Res 2000;260:365-73.
15. Brummer J, Ebrahimnejad A, Flayeh R, et al. cis Interaction of the cell adhesion molecule CEACAM1 with integrin beta(3). Am J Pathol 2001;159:537-46.
16. Retz M, Lehmann J, Roder C, et al. Differential mucin MUC7 gene expression in invasive bladder carcinoma in contrast to uniform MUC1 and MUC2 gene expression in both normal urothelium and bladder carcinoma. Cancer Res 1998;58:5662-6.
17. Thiesen HJ, Juhl H, Arndt R. Selective killing of human bladder cancer cells by combined treatment with A and B chain ricin antibody conjugates. Cancer Res 1987;47:419-23.
18. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 2001;20:6877-88.
19. Pepper NS, Ferrara N, Orel L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992;189:824-31.
20. Alitalo K, Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002;1:219-27.
21. Salven P, Lymboussaki A, Heikkila P, et al. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 1998;153:103-8.
22. Valtola R, Salven P, Heikkila P, et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 1999;154:1381-90.
23. Wartiovaara U, Salven P, Mikkola H, et al. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 1998;80:171-5.
24. Cao Y, Linden P, Farnebo J, et al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA 1998;95:14389-94.
25. Sawa H, Kamada K, Sato H, et al. C-CAM expression in the developing rat central nervous system. Brain Res Dev Brain Res 1994;78:35-43.
26. Crew JP, O'Brien T, Bicknell R, Fuggle S, Cranston D, Harris AL. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates [see comments]. J Urol 1999;161:799-804.
27. Crew JP. Vascular endothelial growth factor: an important angiogenic mediator in bladder cancer. Eur Urol 1999;35:2-8.
28. Crew JP, O'Brien T, Bradburn M, et al. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res 1997;57:5281-5.
29. Muenzner P, Dehio C, Fujiwara T, Achtman M, Meyer TF, Gray-Owen SD. Carcinoembryonic antigen family receptor specificity of Neisseria meningitidis Opa variants influences adherence to and invasion of proinflammatory cytokine-activated endothelial cells. Infect Immun 2000;68:3601-7.